The GO analyses showed that the oxidation-reduction, immune system process, metabolic process and P450 pathway were the top biological processes altered during NAFLD/NASH progression, which were attenuated by bicyclol treatment. The gene discussed is CYP2B6; the disease is metabolic dysfunction-associated steatotic liver disease.